Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases.
about
Fracture risk and areal bone mineral density in adolescent females with anorexia nervosa.Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model.Markers of collagen metabolism and insulin-like growth factor binding protein-1 in term infantsEffects of rhIGF-I administration on bone turnover during short-term fasting.Sclerostin levels and bone turnover markers in adolescents with anorexia nervosa and healthy adolescent girls.Adolescent girls with anorexia nervosa have impaired cortical and trabecular microarchitecture and lower estimated bone strength at the distal radiusProduction of recombinant human procollagen type I C-terminal propeptide and establishment of a sandwich ELISA for quantification.Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: relation to height velocity and serum hormone levels.Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation.Effect of electric stimulation on human chondrocytes and mesenchymal stem cells under normoxia and hypoxiaAsthma, Glucocorticoids and GrowthA prospective longitudinal study of urinary excretion of a bone resorption marker in adolescents
P2860
Q33740932-5DE99CDE-27FE-4DD5-82C0-37BFBF398050Q35156234-65826868-2593-443B-AA99-56DF3EFC94C2Q35289619-660AA35D-9C39-4D1B-AC25-CF7CC599D014Q35752710-0E52C3A9-CB7E-48ED-BF7E-1B064798923BQ36143916-D033A3A4-01F3-46CF-88DA-FBE1C9A0E7B9Q36817200-783A9F14-8977-404E-839B-0E76D5A4DBDFQ46436623-97A7E5C4-FAB8-4FD9-8BC8-DD477B525E7FQ47314911-0A7B167B-0D7B-4862-8B6E-44EF2F002FBEQ50966154-A327957F-F196-488D-83F0-FE97DD55C89BQ57173167-AC4D78E1-2811-42AB-A4BA-20D1DFF24D0DQ58250075-7D696BFD-945D-4136-BB8C-F4CABE4E6982Q58309085-26CA2626-B729-4504-B803-FD6844F59DC3
P2860
Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Serum levels of carboxytermina ...... nd in metabolic bone diseases.
@en
Serum levels of carboxytermina ...... nd in metabolic bone diseases.
@nl
type
label
Serum levels of carboxytermina ...... nd in metabolic bone diseases.
@en
Serum levels of carboxytermina ...... nd in metabolic bone diseases.
@nl
prefLabel
Serum levels of carboxytermina ...... nd in metabolic bone diseases.
@en
Serum levels of carboxytermina ...... nd in metabolic bone diseases.
@nl
P2093
P2860
P356
P1476
Serum levels of carboxytermina ...... nd in metabolic bone diseases.
@en
P2093
G I Baroncelli
S Bertelloni
P2860
P2888
P304
P356
10.1007/BF01959087
P577
1992-10-01T00:00:00Z